Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HIC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM182 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLE6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996286 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MOB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRIPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF624 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMPAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOC4-APOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on